Metagenomi Therapeutics (MGX) EBT (2023 - 2026)
Metagenomi Therapeutics (MGX) reported EBT of -$23.0 million for Q1 2026, up 7.59% year-over-year from -$21.4 million in Q1 2025, and down 2.47% quarter-over-quarter from -$22.5 million in Q4 2025.
Metagenomi Therapeutics (MGX) EBT (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of EBT data on file, last reported at -$23.0 million in Q1 2026.
- EBT for Q1 2026 came in at -$23.0 million, up 7.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$86.0 million (down 3.2% YoY), and the FY2025 annual result was -$87.9 million, down 5.21% from the prior year.
- EBT fell to -$23.0 million in Q1 2026 per MGX's latest filing, from -$22.5 million in the prior quarter.
- Over five years, EBT peaked at -$11.1 million in Q2 2023 and troughed at -$25.1 million in Q1 2024.
- A 4-year average of -$19.6 million and a median of -$20.6 million in 2025 frame the typical range for EBT.
- The sharpest annual moves came in 2024 and 2025: EBT plunged 80.45% in 2024, then climbed 8.58% in 2025.
- A 4-year view of EBT shows it stood at -$16.6 million in 2023, then slumped by 48.52% to -$24.6 million in 2024, then grew by 8.58% to -$22.5 million in 2025, then decreased by 2.47% to -$23.0 million in 2026.
- Business Quant data shows MGX's EBT at -$23.0 million in Q1 2026, -$22.5 million in Q4 2025, and -$20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.48 Mn |
| 10 | Metagenomi Therapeutics | 46.60 Mn | 46.60 Mn | - | -23.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.05 Mn |
| Dec 31, 2025 | -22.49 Mn |
| Sep 30, 2025 | -20.63 Mn |
| Jun 30, 2025 | -19.86 Mn |
| Mar 31, 2025 | -24.94 Mn |
| Dec 31, 2024 | -24.61 Mn |
| Sep 30, 2024 | -20.88 Mn |
| Jun 30, 2024 | -12.94 Mn |
| Mar 31, 2024 | -25.15 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Sep 30, 2023 | -18.61 Mn |
| Jun 30, 2023 | -11.11 Mn |
| Mar 31, 2023 | -13.94 Mn |